Rpharmy Earns Key Security Audit, Bolstering Trust in Healthcare Tech

AUSTIN, Texas – April 20, 2026 – Rpharmy, a long-standing provider of healthcare software solutions, today announced the successful completion of its Service Organization Control (SOC) 2® Type II audit, a significant milestone that reinforces its pledge to data security in the high-stakes healthcare industry.

The achievement validates the company's robust controls over an extended period, assuring clients that their systems for managing sensitive medication and patient data are not only well-designed but also operate effectively day-to-day. The audit was conducted by the independent firm Johanson Group LLP.

“In healthcare, the sensitivity of the data we handle is unparalleled. Our customers deserve a partner who treats that responsibility with the utmost seriousness,” said Laura Paxton, Founder and CEO at Rpharmy, in the company's announcement. “Completing our SOC 2 Type II audit is a testament to our team’s dedication to building and maintaining secure, trustworthy solutions. This milestone reflects the security-first culture we’ve built from day one.”

The Gold Standard for Data Security

For technology providers serving the healthcare sector, a SOC 2 Type II report is widely regarded as the gold standard for security assurance. Developed by the American Institute of Certified Public Accountants (AICPA), the SOC 2 framework evaluates how organizations protect customer data based on five Trust Services Criteria: Security, Availability, Confidentiality, Processing Integrity, and Privacy.

Rpharmy’s audit specifically covered the Security, Availability, and Confidentiality criteria, which are critical for healthcare environments. The Security criterion ensures systems are protected against unauthorized access. Availability confirms that systems are operational and accessible as promised, a vital component for clinical workflows. Confidentiality guarantees that information designated as confidential is protected from unauthorized disclosure.

Unlike a Type I audit, which only assesses the design of security controls at a single point in time, the Type II audit provides a more rigorous evaluation. It examines the operational effectiveness of those controls over an extended period, typically six to twelve months. This ongoing assessment offers a much stronger guarantee that a company’s security practices are consistently enforced, not just documented.

Navigating a High-Stakes Digital Environment

The timing of Rpharmy's achievement is particularly relevant. The healthcare industry remains a primary target for cybercriminals, with data breaches growing in both frequency and cost. According to recent industry reports, the average cost of a healthcare data breach has soared to nearly $11 million per incident, the highest of any sector. This financial toll is compounded by regulatory penalties, reputational damage, and, most importantly, the potential disruption to patient care.

Federal regulations like the Health Insurance Portability and Accountability Act (HIPAA) and its HITECH Act extension impose strict rules on how patient data is handled, stored, and protected. While SOC 2 is a voluntary standard, it is highly complementary to HIPAA. Many of the technical and administrative safeguards required by the HIPAA Security Rule—such as access controls, encryption, and incident response planning—are integral components of a SOC 2 audit.

For hospitals and health systems, this makes SOC 2 compliance a critical factor in their third-party risk management programs. When a healthcare provider partners with a software vendor, they are entrusting that vendor with protected health information (PHI). A breach originating from a third-party vendor can create significant legal and financial liability for the healthcare organization itself. As a result, a SOC 2 Type II report has become a baseline requirement for many providers when vetting new technology partners, serving as independent proof of a vendor's commitment to security.

A Dual Commitment to Patient Safety and Data Integrity

For over three decades, Rpharmy has focused on addressing complex challenges in medication safety and patient care. The company develops technology centered on medical formularies, hazardous drug handling, and compliance with standards from organizations like the Joint Commission and the National Institute for Occupational Safety and Health (NIOSH). Its core mission is to safeguard patients and healthcare workers by making essential medication safety information readily accessible.

This new security certification serves as a powerful extension of that mission. In modern healthcare, clinical safety and data security are inextricably linked. The most effective medication safety software is only as reliable as the infrastructure it runs on. By investing in a rigorous, independently verified security program, Rpharmy demonstrates an understanding that protecting the data behind the care is just as critical as the care itself.

The successful audit validates the security of the company's platforms, which are designed to integrate with major Electronic Health Record (EHR) systems. This ensures that the flow of critical information—from formulary data to hazardous drug handling protocols—remains secure, confidential, and consistently available to clinicians at the point of care.

Raising the Bar in a Competitive Field

Rpharmy operates in a specialized market alongside other established players in drug information and safety technology, many of whom also recognize the importance of robust security certifications. By completing its SOC 2 Type II audit, the company not only aligns with industry best practices but also reinforces its position as a trusted and competitive player in the healthcare technology landscape.

The audit's credibility is further bolstered by its execution by Johanson Group LLP, a CPA firm specializing in IT compliance for technology and healthcare companies. Engaging a specialized auditor ensures the evaluation is thorough and adheres to the strict professional standards set by the AICPA.

In an era where digital transformation is reshaping every aspect of healthcare delivery, the foundation of that transformation must be built on trust. For healthcare organizations evaluating technology partners, this audit provides a clear and transparent benchmark of Rpharmy's security posture. Existing and prospective customers can request a copy of the SOC 2 report to gain detailed insight into the company's control environment, fostering a partnership based on transparency and a shared commitment to security.